MLC1 and megalencephalic leukoencephalopathy with subcortical cysts: Approximately 76% of patients present mutations in MLC1, 22% in HEPACAM and 2% of MLC cases cannot be explained by mutations in these two genes, suggesting that others might be implied in the disease [2].